VNDA: 50% | Vanda Pharmaceuticals shares are trading higher after the company announced that it submitted three proposals since February to acquire all of the outstanding shares of common stock of Vanda Pharmaceuticals and confirmed that its most recent proposal to acquire Vanda remains open for Vanda and its Board of Directors to consider.
INVO: 127% | INVO BioScience shares are trading higher after the company reported a year-over-year increase in Q4 revenue results and said it remains on track to reach its goal of reaching break-even or profitability within its current operations in 2024.
CXAI: 35% | CXApp share are trading higher after the company announced 24% ARR growth in 2023.